The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- November 2014
- DOI:
- 10.1371/journal.pone.0112394
- Bibcode:
- 2014PLoSO...9k2394O